However, the absolute uptake of FAP for tumor was low and the tumor-to-background ratio was high, lower uptake of FAP with a higher tumor-to-background ratio were observed in gliomas in other brain studies (168–170). The gene discussed is FAP; the disease is central nervous system cancer.